QualityStocksNewsBreaks Archives - Page 773 of 1575

WednesdayJul 21, 2021 11:06 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition

Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced the acquisition of Global Agrochemicals Innovator, a global developer and supplier of environmentally responsible and organically natural agrochemicals, and anticipates completing that transaction in the coming weeks. In addition, PBIO announced that it has purchased specialized, proprietary material worth more than $500,000 to be used to fulfill initial demand for its ecofriendly, agrochemical pest control and growth stimulant products. "We have developed a very aggressive…

WednesdayJul 21, 2021 10:45 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. According to the update, the study demonstrated that DehydraTECH(TM)-enabled colchicine, the latest of several drugs Lexaria has successfully tested with known SARS-CoV-2 antiviral properties, benefited from the company’s proprietary formulation and processing, resulting in significantly increased delivery. The study also examined absorption with two other antiviral drugs previously untested by Lexaria; however, the bloodstream delivery findings were unremarkable and further work is required should the company decide to pursue additional testing with…

WednesdayJul 21, 2021 10:24 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), University of Michigan to Collaborate in Phase 2a Clinical Trial for Fibromyalgia

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced its plans to conduct a phase 2a clinical trial with the Chronic Pain & Fatigue Research Center in the Department of Anesthesiology at the University of Michigan Medical School. According to the update, the open-label trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia. The treatment is designed to leverage the neuroplasticity benefits of psilocybin to target nociplastic pain originating in the central…

WednesdayJul 21, 2021 9:43 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Historically High Productivity Rates for Platosa Mine

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced second quarter 2021 production results from the Platosa Mine in Durango, Mexico. Among the highlights, the company reported silver equivalent (“AgEq”) production of 487,009 oz. In addition, Platosa achieved its fourth consecutive quarter of over 21,000 tonnes mined and milled, with record tonnes mined (86,316) and milled (88,648) over the trailing twelve months. “Platosa delivered a fourth consecutive quarter of production at historically high productivity rates,” said Brendan Cahill, president and CEO of Excellon Resources. “We continue to see room for improvement, with our ongoing work to improve recoveries at…

TuesdayJul 20, 2021 2:53 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Issuance of New US Patents

Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI (R) Stick disposable electronic nicotine delivery system (“ENDS”), which is intended exclusively for adults 21 and over. Today the company announced that the United States Patent and Trademark Office (“USPTO”) has issued two additional U.S. patents to Bidi(R) Vapor: patent numbers 11,064,735 and 11,064,736. In addition, patent numbers 11,013,261 and 10,932,491, which were previously pending, have also been granted. “These newly issued patents add valuable coverage to our growing patent portfolio and in our opinion represent the future of the electronic…

TuesdayJul 20, 2021 2:44 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTC: NHHHF) Engages Sussex Strategy Group for Government Relations Services

FuelPositive (TSX.V: NHHH) (OTC: NHHHF), a Canadian-based growth stage company committed to providing commercially viable and sustainable energy solutions, today announced that it has hired Sussex Strategy Group to provide government relations services in Canada. “As a Canadian growth-stage technology company focused on developing clean technologies to fight climate change, we know we share a lot of goals with the federal government and many provincial/territorial governments across Canada,” said FuelPositive CEO Ian Clifford. “Sussex Strategy Group is the right team to help us navigate the government landscape so we can share the excitement of our core technology and discuss with…

TuesdayJul 20, 2021 2:36 pm

QualityStocksNewsBreaks – Riley Exploration Permian, Inc. (NYSE American: REPX) Secures $50M in Follow-On

Riley Exploration Permian (NYSE American: REPX), an independent oil and natural gas company, recently closed a public offering resulting in proceeds of roughly $50 million, before deducting the underwriting discount and estimated expenses. The offering was comprised of 1,666,667 shares of common stock sold at the public offering price of $30 each. REPX granted the underwriters a 30-day option to purchase up to 250,000 additional shares of its common stock. Roth Capital Partners acted as joint lead manager for the offering. To view the full press release, visit https://ibn.fm/7bpyx About Riley Exploration Permian Riley Permian is an independent oil and…

TuesdayJul 20, 2021 2:01 pm

QualityStocksNewsBreaks – Infobird Co. Ltd.’s (NASDAQ: IFBD) Successful SaaS Launch Paves Way for Financial Industry Expansion

Infobird (NASDAQ: IFBD), a software-as-a-service (“SaaS”) provider of artificial intelligence (“AI”) powered customer engagement solutions, today announced the successful implementation of its Intelligent Quality Inspection SaaS with one of China’s leading fintech companies. Infobird's solution enabled the fintech client to realize intelligent management and operation of its customer service platform and sets the foundation for further upgrades. Infobird has continuously promoted the implementation of intelligent quality inspection in various industries in recent years, effectively expanding application boundaries. Since launch, Infobird's Intelligent Quality Inspection, a standardized, intelligent SaaS product that can empower clients to better track engagement between customer service or…

TuesdayJul 20, 2021 1:46 pm

QualityStocksNewsBreaks – The Alkaline Water Company Inc.’s (NASDAQ: WTER) (CSE: WTER) Alkaline88 Water to be Available in Over 800 Gyms Nationwide via Distribution Agreement

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), today announced that it has secured a distribution agreement with Premier Distribution Services (“PDS”). Per the terms of the agreement, PDS will distribute the entire Alkaline88 bottled water to over 800 gyms, personal training studios, smoothie bars and sports nutrition stores across the country. “This is a wonderful opportunity for the company as Premier Distribution Services will be carrying all of our Alkaline88(R) bottled waters in coolers across the country.…

TuesdayJul 20, 2021 12:33 pm

QualityStocksNewsBreaks – Why Lexaria Bioscience Corp. (NASDAQ: LEXX) Is ‘One to Watch’

Lexaria Bioscience Corp. (NASDAQ: LEXX) is the global innovator behind the patented DehydraTECH(TM) technology. DehydraTECH increases the effectiveness of lipophilic (fat-soluble) drugs and active ingredients and improves the way active pharmaceutical ingredients enter the bloodstream. It speeds up delivery, increases bioavailability, increases brain absorption, improves drug potency, reduces drug administration cost and masks unwanted taste. A recent article reads, “Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats. The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription…

Site Search

Company Search

Category: QualityStocksNewsBreaks